摘要:
To provide a pharmaceutical composition containing a 2-nitroimidazole derivative, which has high solubility in an aqueous carrier and high stability. The pharmaceutical composition is characterized by containing 1-(1-hydroxymethyl-2,3-dihydroxypropyl)oxymethyl-2-nitroimidazole and creatinine, and containing creatinine of 0.001 to 1 part by mass with respect to 1 part by mass of 1-(1-hydroxymethyl-2,3-dihydroxypropyl)oxymethyl-2-nitroimidazole .
摘要:
Disclosed is a method for producing a 2-nitroimidazole derivative having an acyclic sugar chain in a side chain which is suitable for production of a derivative having a radioisotope. Specifically disclosed is a method for producing 1-(1- benzoyloxymethyl-2-hydroxyethyl)oxymethyl-2-nitroimidazole, which is characterized in that 1-O-benzoylglycerin is obtained by reacting glycerin with a benzoylating agent, then 4-benzoyloxymethyl-1,3-dioxolane is obtained by reacting 1-O-benzoylglycerin with dimethoxymethane in the presence of a dehydrating agent, and then 4-benzoyloxymethyl-1,3-dioxolane is reacted with 2-nitroimidazole or 2-nitro-1-trialkylsilylimidazole in the presence of a Lewis acid.
摘要:
To provide a pharmaceutical composition which can enhance the storage stability of 1-(1-hydroxymethyl-2,3-dihydroxypropyloxymethyl)-2-nitroimidazole without impairing the effect of the compound. The pharmaceutical composition includes 1-(1-hydroxymethyl-2,3-dihydroxypropyloxymethyl)-2-nitroimidazole, which is represented by formula (1) :
摘要:
Disclosed is a method for producing a 2-nitroimidazole derivative having an acyclic sugar chain in a side chain which is suitable for production of a derivative having a radioisotope. Specifically disclosed is a method for producing 1-(1- benzoyloxymethyl-2-hydroxyethyl)oxymethyl-2-nitroimidazole, which is characterized in that 1-O-benzoylglycerin is obtained by reacting glycerin with a benzoylating agent, then 4-benzoyloxymethyl-1,3-dioxolane is obtained by reacting 1-O-benzoylglycerin with dimethoxymethane in the presence of a dehydrating agent, and then 4-benzoyloxymethyl-1,3-dioxolane is reacted with 2-nitroimidazole or 2-nitro-1-trialkylsilylimidazole in the presence of a Lewis acid.